NIPRO ELISIO™ -H HEMODIALYZER ELISIO™-17HRecalls & reported problems
Nipro Medical Corporation · Surface area 1.7m² Max.TMP:66kPa(500mmHg) · Class 2
All models of NIPRO ELISIO -H HEMODIALYZER (5)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 12
- Deaths reported
- 2
- Injuries reported
- 5
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 12 adverse event reports that list this exact device (DI 00383790007108), received between Sep 11, 2019 and Dec 12, 2024 — classified as 2 deaths, 5 injuries, 5 malfunctions.
The most frequently reported specific device problem is “Fluid/Blood Leak” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem7
- Fluid/Blood Leak4
- Leak/Splash1
Patient problems
- Convulsion/Seizure4
- High Blood Pressure/ Hypertension4
- Blood Loss3
- Death2
- Decreased Respiratory Rate2
- Hemorrhage/Blood Loss/Bleeding2
- Loss of consciousness2
- Low Oxygen Saturation2
Recent adverse event reports
The 12 most recent of 12 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 12, 2024Fluid/Blood Leak; Fluid/Blood Leak
DURING THE BEGINNING OF TREATMENT, MACHINE ALARMED FOR BLOOD LEAK. BLOOD LEAK CONFIRMED WITH POSITIVE BLOOD LEAK STRIP. PER FACILITY POLICIES AND PROCEDURES, THEY WERE UNABLE TO RETURN THE PATIENT'S BLOOD (APPROXIMATELY 200-250ML OF BLOOD IN EXTRACORPOREAL SYSTEM). PATIENT WAS PLACED ON A NEW EXTRACORPOREAL SYSTEM TO COMPLETE TREATMENT. NO INTERVENTION NECESSARY. NO SAMPLES AVAILABLE, NO ADDITIONAL INFORMATION PROVIDED.
Patient problems: Hemorrhage/Blood Loss/Bleeding
MAUDE report 20914440 ↗MalfunctionDec 12, 2024Fluid/Blood Leak; Fluid/Blood Leak
DURING THE BEGINNING OF TREATMENT, MACHINE ALARMED FOR BLOOD LEAK. BLOOD LEAK CONFIRMED WITH POSITIVE BLOOD LEAK STRIP. PER FACILITY POLICIES AND PROCEDURES, THEY WERE UNABLE TO RETURN THE PATIENT'S BLOOD (APPROXIMATELY 200-250ML OF BLOOD IN EXTRACORPOREAL SYSTEM). PATIENT WAS PLACED ON A NEW EXTRACORPOREAL SYSTEM TO COMPLETE TREATMENT. NO INTERVENTION NECESSARY. NO SAMPLES AVAILABLE, NO ADDITIONAL INFORMATION PROVIDED.
Patient problems: Hemorrhage/Blood Loss/Bleeding
MAUDE report 20914244 ↗DeathMay 23, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AT 10: 54 AM, WITH 34 MINUTES INTO A 2.5 HRS TREATMENT, PATIENT SAID HE NEEDS TO USE THE RESTROOM DUE TO BOWEL MOVEMENT AND WAS RESTLESS, BP WAS 84/42 MMHG, P=67. STAFF PUT PATIENT ON T POSITION AND STAFF NOTICED AFTER THAT PATIENT HAD A BLANK STARE AND WAS UNRESPONSIVE. NURSE WAS CALLED, BLOOD WAS RETURNED, AND TREATMENT WAS ENDED. NURSE DID A CHEST RUB, GAVE OXYGEN AND 911 WAS CALLED. AT 11:03 AM BLOOD SUGAR WAS 113MG/DL. 11:06 AM - BP WAS 127/66, P 119, BUT RESPIRATORY RATE WAS ONLY 2 AND NURSE WAS GIVING OXYGEN THROUGH AMBU BAG. PARAMEDICS CAME AND PRONOUNCED THE PATIENT DECEASED AT 11:17 AM. FAMILY WAS CONTACTED AND DECIDED NOT TO SEND PATIENT TO THE HOSPITAL. PATIENT HAD PREVIOUSLY SIGNED A DNR ON (B)(6) 2022. PATIENT HAS A HISTORY OF NON-COMPLIANCE, MISSING AND NOT COMPLETING TREATMENTS. PATIENT TREATMENT ORDERS/INFORMATION: TX TIME - 2.5 HRS; BFR - 300; DFR - 500; EDW - (B)(6). PATIENT CAME IN @ (B)(6), GOAL SET AT 600 ML. BP AT START OF TREATMENT - 90/51 MMHG, P= 66. ONLY HEPARIN 2000 UNITS WAS GIVEN. NO NEW MEDICATIONS STARTED. OTHER PRODUCTS USED DURING THE EVENT: NIPRO SDX BLOOD TUBING SET - 20F15; NIPRO AVF TULIP 16G NEEDLE - 21J06B; CITRIC ACID - AC-200 - N1H007; NIPR
Patient problems: Decreased Respiratory Rate; Loss of consciousness; Low Oxygen Saturation
MAUDE report 14477874 ↗DeathMay 23, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AT 10: 54 AM, WITH 34 MINUTES INTO A 2.5 HRS TREATMENT, PATIENT SAID HE NEEDS TO USE THE RESTROOM DUE TO BOWEL MOVEMENT AND WAS RESTLESS, BP WAS 84/42 MMHG, P=67. STAFF PUT PATIENT ON T POSITION AND STAFF NOTICED AFTER THAT PATIENT HAD A BLANK STARE AND WAS UNRESPONSIVE. NURSE WAS CALLED, BLOOD WAS RETURNED, AND TREATMENT WAS ENDED. NURSE DID A CHEST RUB, GAVE OXYGEN AND 911 WAS CALLED. AT 11:03 AM BLOOD SUGAR WAS 113MG/DL. 11:06 AM - BP WAS 127/66, P 119, BUT RESPIRATORY RATE WAS ONLY 2 AND NURSE WAS GIVING OXYGEN THROUGH AMBU BAG. PARAMEDICS CAME AND PRONOUNCED THE PATIENT DECEASED AT 11:17 AM. FAMILY WAS CONTACTED AND DECIDED NOT TO SEND PATIENT TO THE HOSPITAL. PATIENT HAD PREVIOUSLY SIGNED A DNR ON (B)(6) 2022. PATIENT HAS A HISTORY OF NON-COMPLIANCE, MISSING AND NOT COMPLETING TREATMENTS. PATIENT TREATMENT ORDERS/INFORMATION: TX TIME - 2.5 HRS; BFR - 300; DFR - 500; EDW - (B)(6). PATIENT CAME IN @ (B)(6), GOAL SET AT 600 ML. BP AT START OF TREATMENT - 90/51 MMHG, P= 66. ONLY HEPARIN 2000 UNITS WAS GIVEN. NO NEW MEDICATIONS STARTED. OTHER PRODUCTS USED DURING THE EVENT: NIPRO SDX BLOOD TUBING SET - 20F15; NIPRO AVF TULIP 16G NEEDLE - 21J06B; CITRIC ACID - AC-200 - N1H007; NIPR
Patient problems: Decreased Respiratory Rate; Loss of consciousness; Low Oxygen Saturation
MAUDE report 14477252 ↗InjuryMay 23, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
58 MINUTES INTO A TWO-HOUR DIALYSIS TREATMENT THE AFFECTED PATIENT STARTED VOMITING AND SUBSEQUENTLY HAD A WITNESSED GRAND-MAL SEIZURE. THIS LASTED 1-2 MINUTES AND THEN SUBSIDED. THE TREATMENT WAS ENDED WITH A TOTAL OF 489 ML UF(ULTRAFILTRATION). EMS WAS DISPATCHED AND BY THE TIME THEY ARRIVED IN THE FACILITY THE PATIENT WAS FULLY CONSCIOUS AND RECOVERED FROM THE EVENT. THE NURSE NOTED THAT THERE WAS NO CHANGE IN VITAL SIGNS BEFORE THE EVENT, AND NO INDICATION TO HER THAT THERE WAS AN IMPENDING EVENT. THIS PATIENT IS AN ESTABLISHED DIALYSIS PATIENT WITH NO HISTORY OF SEIZURES. PER THE NURSE, AFTER THE EVENT THE PATIENTS BLOOD PRESSURE WAS SLIGHTLY ELEVATED, BUT WITHIN NORMAL RANGE. THE PATIENT WAS TAKEN TO THE HOSPITAL AND CLEARED TO RETURN BACK TO THE NURSING HOME THAT SAME DAY. THE PATIENT RECEIVED DIALYSIS TREATMENTS WEDNESDAY 4/20/2022, THURSDAY 4/21/2022 AND FRIDAY 4/22/2022 WITH NO ADVERSE EVENTS. 4/25/2022: RN SAID PATIENT DIALYZED WITH NO ISSUES. PATIENT HAD HISTORY OF STROKE BUT NO HISTORY OF SEIZURES. PER NURSE, NO MEDICATIONS WERE GIVEN DURING THE TREATMENT WHEN THE EVENT HAPPENED, AND NO NEW MEDICATION WAS STARTED. PATIENT HAS CVC BUT HAD AVF SURGERY 4/11/2022. VITAL S
Patient problems: Convulsion/Seizure; High Blood Pressure/ Hypertension
MAUDE report 14472862 ↗InjuryMay 23, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
58 MINUTES INTO A TWO-HOUR DIALYSIS TREATMENT THE AFFECTED PATIENT STARTED VOMITING AND SUBSEQUENTLY HAD A WITNESSED GRAND-MAL SEIZURE. THIS LASTED 1-2 MINUTES AND THEN SUBSIDED. THE TREATMENT WAS ENDED WITH A TOTAL OF 489 ML UF (ULTRAFILTRATION). EMS WAS DISPATCHED AND BY THE TIME THEY ARRIVED IN THE FACILITY THE PATIENT WAS FULLY CONSCIOUS AND RECOVERED FROM THE EVENT. THE NURSE NOTED THAT THERE WAS NO CHANGE IN VITAL SIGNS BEFORE THE EVENT, AND NO INDICATION TO HER THAT THERE WAS AN IMPENDING EVENT. THIS PATIENT IS AN ESTABLISHED DIALYSIS PATIENT WITH NO HISTORY OF SEIZURES. PER THE NURSE, AFTER THE EVENT THE PATIENTS BLOOD PRESSURE WAS SLIGHTLY ELEVATED, BUT WITHIN NORMAL RANGE. THE PATIENT WAS TAKEN TO THE HOSPITAL AND CLEARED TO RETURN BACK TO THE NURSING HOME THAT SAME DAY. THE PATIENT RECEIVED DIALYSIS TREATMENTS WEDNESDAY (B)(6) 2022, THURSDAY (B)(6) 2022 AND FRIDAY (B)(6) 2022 WITH NO ADVERSE EVENTS. (B)(6) 2022: RN SAID PATIENT DIALYZED WITH NO ISSUES. PATIENT HAD HISTORY OF STROKE BUT NO HISTORY OF SEIZURES. PER NURSE, NO MEDICATIONS WERE GIVEN DURING THE TREATMENT WHEN THE EVENT HAPPENED, AND NO NEW MEDICATION WAS STARTED. PATIENT HAS CVC BUT HAD AVF SURGERY (B)(6) 202
Patient problems: Convulsion/Seizure; High Blood Pressure/ Hypertension
MAUDE report 14472211 ↗InjuryMay 23, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
58 MINUTES INTO A TWO-HOUR DIALYSIS TREATMENT THE AFFECTED PATIENT STARTED VOMITING AND SUBSEQUENTLY HAD A WITNESSED GRAND-MAL SEIZURE. THIS LASTED 1-2 MINUTES AND THEN SUBSIDED. THE TREATMENT WAS ENDED WITH A TOTAL OF 489 ML UF(ULTRAFILTRATION). EMS WAS DISPATCHED AND BY THE TIME THEY ARRIVED IN THE FACILITY THE PATIENT WAS FULLY CONSCIOUS AND RECOVERED FROM THE EVENT. THE NURSE NOTED THAT THERE WAS NO CHANGE IN VITAL SIGNS BEFORE THE EVENT, AND NO INDICATION TO HER THAT THERE WAS AN IMPENDING EVENT. THIS PATIENT IS AN ESTABLISHED DIALYSIS PATIENT WITH NO HISTORY OF SEIZURES. PER THE NURSE, AFTER THE EVENT THE PATIENTS BLOOD PRESSURE WAS SLIGHTLY ELEVATED, BUT WITHIN NORMAL RANGE. THE PATIENT WAS TAKEN TO THE HOSPITAL AND CLEARED TO RETURN BACK TO THE NURSING HOME THAT SAME DAY. THE PATIENT RECEIVED DIALYSIS TREATMENTS WEDNESDAY (B)(6) 2022, THURSDAY (B)(6) 2022 AND FRIDAY (B)(6) 2022 WITH NO ADVERSE EVENTS. (B)(6) 2022: RN SAID PATIENT DIALYZED WITH NO ISSUES. PATIENT HAD HISTORY OF STROKE BUT NO HISTORY OF SEIZURES. PER NURSE, NO MEDICATIONS WERE GIVEN DURING THE TREATMENT WHEN THE EVENT HAPPENED, AND NO NEW MEDICATION WAS STARTED. PATIENT HAS CVC BUT HAD AVF SURGERY (B)(6) 2022
Patient problems: Convulsion/Seizure; High Blood Pressure/ Hypertension
MAUDE report 14469711 ↗InjuryMay 23, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
58 MINUTES INTO A TWO-HOUR DIALYSIS TREATMENT THE AFFECTED PATIENT STARTED VOMITING AND SUBSEQUENTLY HAD A WITNESSED GRAND-MAL SEIZURE. THIS LASTED 1-2 MINUTES AND THEN SUBSIDED. THE TREATMENT WAS ENDED WITH A TOTAL OF 489 ML UF(ULTRAFILTRATION). EMS WAS DISPATCHED AND BY THE TIME THEY ARRIVED IN THE FACILITY THE PATIENT WAS FULLY CONSCIOUS AND RECOVERED FROM THE EVENT. THE NURSE NOTED THAT THERE WAS NO CHANGE IN VITAL SIGNS BEFORE THE EVENT, AND NO INDICATION TO HER THAT THERE WAS AN IMPENDING EVENT. THIS PATIENT IS AN ESTABLISHED DIALYSIS PATIENT WITH NO HISTORY OF SEIZURES. PER THE NURSE, AFTER THE EVENT THE PATIENTS BLOOD PRESSURE WAS SLIGHTLY ELEVATED, BUT WITHIN NORMAL RANGE. THE PATIENT WAS TAKEN TO THE HOSPITAL AND CLEARED TO RETURN BACK TO THE NURSING HOME THAT SAME DAY. THE PATIENT RECEIVED DIALYSIS TREATMENTS WEDNESDAY(B)(6) 2022, THURSDAY (B)(6) 2022 AND FRIDAY (B)(6) 2022 WITH NO ADVERSE EVENTS. (B)(6) 2022: RN SAID PATIENT DIALYZED WITH NO ISSUES. PATIENT HAD HISTORY OF STROKE BUT NO HISTORY OF SEIZURES. PER NURSE, NO MEDICATIONS WERE GIVEN DURING THE TREATMENT WHEN THE EVENT HAPPENED, AND NO NEW MEDICATION WAS STARTED. PATIENT HAS CVC BUT HAD AVF SURGERY (B)(6) 2022.
Patient problems: Convulsion/Seizure; High Blood Pressure/ Hypertension
MAUDE report 14469500 ↗MalfunctionApr 8, 2020Leak/Splash; Leak/Splash
WITH 2 HOURS LEFT OF DIALYSIS TREATMENT, STAFF NOTICED THAT BLOOD WAS VISIBLE ON THE ARTERIAL HANSON DIALYSATE LINE. TREATMENT WAS STOPPED AND TERMINATED IMMEDIATELY, BLOOD WAS NOT RETURNED. THE DIALYSIS MACHINE WAS PULLED OUT OF THE HOSPITAL UNIT FLOOR AND NO NEW SET UP WAS STARTED. PATIENT HAD SHORTNESS OF BREATH, BUT STAFF WAS NOT SURE IF THE PATIENT HAD THESE SYMPTOMS PRIOR TO TREATMENT. TREATMENT INFO: TIME = 4 HRS, BFR/DFR = 300/600, HEPARIN = GOT 1900 UNITS DURING TREATMENT (DIDN'T SPECIFY IF IT'S BOLUS/MAINTENANCE), NO OTHER MEDICATIONS DURING TREATMENT, HAS CVC, USING GAMBRO MACHINE, 5TH TREATMENT ON ELISIO. ADDITIONAL INFORMATION RECEIVED 03/30/2020: CAUSE OF PATIENT DEATH WAS NATURAL; PER CORONER. BLOOD CULTURES WERE OBTAINED AND NEGATIVE ON DAY OF EVENT. PATIENT HAD MULTIPLE COMORBIDITIES INCLUDING CHF (CONGESTIVE HEART FAILURE) WITH REDUCED EJECTION FRACTION, AF(ARTERIAL FIBRILLATION) WITH RVR(RAPID VENTRICULAR RATE), CKD(CHRONIC KIDNEY DISEASE), AND OBESITY. HE DID NOT TOLERATE HD DUE PRIMARILY TO HYPOTENSION ON TREATMENT WITH INABILITY TO REMOVE FLUID AND WAS MASSIVELY FLUID OVERLOADED. PATIENT DID NOT WISH TO PURSUE DIALYSIS, AND CHOSE A COMFORT BASED APPROACH AFTER
Patient problems: Blood Loss; Death
MAUDE report 9935944 ↗MalfunctionApr 8, 2020Adverse Event Without Identified Device or Use Problem
WITH 2 HOURS LEFT OF DIALYSIS TREATMENT, STAFF NOTICED THAT BLOOD WAS VISIBLE ON THE ARTERIAL HANSON DIALYSATE LINE. TREATMENT WAS STOPPED AND TERMINATED IMMEDIATELY, BLOOD WAS NOT RETURNED. THE DIALYSIS MACHINE WAS PULLED OUT OF THE HOSPITAL UNIT FLOOR AND NO NEW SET UP WAS STARTED. PATIENT HAD SHORTNESS OF BREATH, BUT STAFF WAS NOT SURE IF THE PATIENT HAD THESE SYMPTOMS PRIOR TO TREATMENT. TREATMENT INFO: TIME = 4 HRS. BFR/DFR = 300/600. HEPARIN = GOT 1900 UNITS DURING TREATMENT (DIDN'T SPECIFY IF IT'S BOLUS/MAINTENANCE). NO OTHER MEDICATIONS DURING TREATMENT. HAS CVC. USING GAMBRO MACHINE. 5TH TREATMENT ON ELISIO. ADDITIONAL INFORMATION RECEIVED 03/30/2020: CAUSE OF PATIENT DEATH WAS NATURAL; PER CORONER. BLOOD CULTURES WERE OBTAINED AND NEGATIVE ON DAY OF EVENT. PATIENT HAD MULTIPLE COMORBIDITIES INCLUDING CHF (CONGESTIVE HEART FAILURE) WITH REDUCED EJECTION FRACTION, AF(ARTERIAL FIBRILLATION) WITH RVR(RAPID VENTRICULAR RATE), CKD(CHRONIC KIDNEY DISEASE), AND OBESITY. HE DID NOT TOLERATE HD DUE PRIMARILY TO HYPOTENSION ON TREATMENT WITH INABILITY TO REMOVE FLUID AND WAS MASSIVELY FLUID OVERLOADED. PATIENT DID NOT WISH TO PURSUE DIALYSIS, AND CHOSE A COMFORT BASED APPROACH AFTER
Patient problems: Death; Dyspnea; Low Blood Pressure/ Hypotension
MAUDE report 9935741 ↗MalfunctionSep 11, 2019Fluid/Blood Leak; Fluid/Blood Leak
15 MINUTES INTO A 3.5 HRS DIALYSIS TREATMENT, MACHINE ALARMED FOR BLOOD LEAK. BLOOD LEAK WAS CONFIRMED WITH A POSITIVE BLOOD LEAK TEST STRIP. PATIENT'S BLOOD WAS NOT RETURNED, LOST APPROXIMATELY 150ML OF BLOOD. PATIENT WAS IN GOOD CONDITION AND DID NOT REQUIRE ANY ADDITIONAL MEDICATIONS, A NEW MACHINE WAS SET UP. PATIENT WAS ABLE TO COMPLETE THEIR DIALYSIS TREATMENT. PRESENT HEMOGLOBIN WAS 11.3. DIALYSIS CONDITIONS: PRIMED WITH BFR OF 100ML/HR WITH 300ML VOLUME. TREATMENT TIME IS 3.5 HRS, 400 BFR, 600 DFR. MEDICATIONS: ZEMPLAR 6MCG. VASCULAR ACCESS: RIGHT (AVF) ARTERIAL VENOUS FISTULA. OTHER DEVICES USED: FRESENIUS DIALYSIS MACHINE, STREAMLINE BLOODLINES, MASTERGUARD.
Patient problems: Blood Loss
MAUDE report 8994592 ↗InjurySep 11, 2019Fluid/Blood Leak
15 MINUTES INTO A 3.5HRS DIALYSIS TREATMENT, MACHINE ALARMED FOR BLOOD LEAK. BLOOD LEAK WAS CONFIRMED WITH A POSITIVE BLOOD LEAK TEST STRIP. PATIENT'S BLOOD WAS NOT RETURNED, LOST APPROXIMATELY 150ML OF BLOOD. PATIENT WAS IN GOOD CONDITION AND DID NOT REQUIRE ANY ADDITIONAL MEDICATIONS, A NEW MACHINE WAS SET UP. PATIENT WAS ABLE TO COMPLETE THEIR DIALYSIS TREATMENT. PRESENT HEMOGLOBIN WAS 11.3. DIALYSIS CONDITIONS: PRIMED WITH BFR OF 100ML/HR WITH 300ML VOLUME. TREATMENT TIME IS 3.5HRS, 400 BFR, 600 DFR. MEDICATIONS: ZEMPLAR 6MCG. VASCULAR ACCESS: RIGHT (AVF) ARTERIAL VENOUS FISTULA. OTHER DEVICES USED: FRESENIUS DIALYSIS MACHINE, STREAMLINE BLOODLINES, MASTERGUARD.
Patient problems: Blood Loss
MAUDE report 8993747 ↗
Other Dialyzer, high permeability with or without sealed dialysate system devices
- Optiflux® 0500318EFresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system1 recall6 deaths2,849 reports
- 2008® Series Hemodialysis Machines 190713Fresenius Usa, Inc. · Dialyzer, high permeability with or without sealed dialysate system3 recalls37 deaths893 reports
- 2008T BlueStar Hemodialysis Machine 191126Fresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system5 recalls10 deaths441 reports
- 2008® Series Hemodialysis Machines 190766Fresenius Usa, Inc. · Dialyzer, high permeability with or without sealed dialysate system4 recalls15 deaths370 reports
- 2008T BlueStar Hemodialysis Machine 191130Fresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system4 recalls7 deaths272 reports
- 2008® Series Hemodialysis Machines 190610Fresenius Usa, Inc. · Dialyzer, high permeability with or without sealed dialysate system1 recall15 deaths335 reports
- Optiflux® 0500320EFresenius Medical Care Holdings, Inc. · Dialyzer, high permeability with or without sealed dialysate system2 recalls242 reports
- REVACLEAR 300Gambro Renal Products, Inc. · Dialyzer, high permeability with or without sealed dialysate system3 recalls125 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page